Dr. Eric Lawitz
Claim this profileTexas Liver Institute
Expert in Nonalcoholic Steatohepatitis
Expert in Non-alcoholic Fatty Liver Disease
39 reported clinical trials
41 drugs studied
Area of expertise
1Nonalcoholic Steatohepatitis
Global LeaderStage I
Stage II
2Non-alcoholic Fatty Liver Disease
Global LeaderStage I
Stage II
Affiliated Hospitals
Clinical Trials Eric Lawitz is currently running
GSK4532990
for Alcohol-related Liver Disease
The goal of this study is to assess the safety and efficacy of GSK4532990 in participants with alcohol-related liver disease.
Recruiting0 awards Phase 2
Lepodisiran
for Liver Dysfunction
The main purpose of this study is to evaluate how much lepodisiran gets into the blood stream and how long it takes the body to get rid of it when given as a subcutaneous (SC) injection under the skin to participants with mild, moderate, or severe liver function impairment compared to participants with normal liver function. The study will also evaluate how well lepodisiran is tolerated and what side effects may occur in these participants. The study will last up to approximately 9 weeks, excluding screening.
Recruiting1 award Phase 12 criteria
More about Eric Lawitz
Clinical Trial Related5 years of experience running clinical trials · Led 39 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Eric Lawitz has experience with
- Placebo
- GSK4532990
- Saroglitazar Magnesium
- Belapectin
- Lanifibranor
- PHIN-214
Breakdown of trials Eric Lawitz has run
Nonalcoholic Steatohepatitis
Non-alcoholic Fatty Liver Disease
Liver disease
Healthy Subjects
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eric Lawitz specialize in?
Eric Lawitz focuses on Nonalcoholic Steatohepatitis and Non-alcoholic Fatty Liver Disease. In particular, much of their work with Nonalcoholic Steatohepatitis has involved Stage I patients, or patients who are Stage II.
Is Eric Lawitz currently recruiting for clinical trials?
Yes, Eric Lawitz is currently recruiting for 6 clinical trials in San Antonio Texas. If you're interested in participating, you should apply.
Are there any treatments that Eric Lawitz has studied deeply?
Yes, Eric Lawitz has studied treatments such as Placebo, GSK4532990, Saroglitazar Magnesium.
What is the best way to schedule an appointment with Eric Lawitz?
Apply for one of the trials that Eric Lawitz is conducting.
What is the office address of Eric Lawitz?
The office of Eric Lawitz is located at: Texas Liver Institute, San Antonio, Texas 78215 United States. This is the address for their practice at the Texas Liver Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.